March 11, 2020 / 6:14 AM / a month ago

BRIEF-Targovax Q4 Oper Loss Narrows To NOK 39.3 Mln

March 11 (Reuters) - Targovax ASA:

* : FOURTH QUARTER 2019 RESULTS

* Q4 TOTAL OPERATING REVENUE NOK 2.2 MILLION VERSUS NOK 6,000 YEAR AGO

* Q4 OPERATING LOSS NOK 39.3 MILLION VERSUS LOSS NOK 42.2 MILLION YEAR AGO

* OVER THE NEXT 12 MONTHS, WE EXPECT SEVERAL ADDITIONAL DATA READ-OUTS FROM OUR ONGOING ONCOS-102 CLINICAL TRIALS, WHICH WE ANTICIPATE WILL FURTHER SOLIDIFY THE ENCOURAGING EARLY FINDINGS.

* WE CONTINUE TO BELIEVE THAT MUTRAS IS AN IMPORTANT TARGET

* WILL CONTINUE TO PURSUE PARTNERSHIPS AND COLLABORATIONS TO TARGET MUTRAS – AS BEFORE WITH THE TG VACCINE AND GOING FORWARD ALSO WITH NOVEL IMMUNOLOGICAL APPROACHES. Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below